Effects on heart rate variability of isosorbide-5-mononitrate and metoprolol in patients with recent onset of angina pectoris

Cardiology

Volumn 89, Issue 2, 1998, Pages 87-93

  Wennerblom, Bertil ^a   Lurje, Leon ^a   Westberg, Staffan ^a   Johansson, Mats ^a   Lomsky, Milan ^a   Vahisalo, Rein ^a   Hjalmarson, Åke ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Angina pectoris; Heart rate variability; Isosorbide 5 mononitrate; Metoprolol

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORONARY VASODILATING AGENT; ISOSORBIDE 5 NITRATE; METOPROLOL;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL ARTICLE; FEMALE; HEART MUSCLE ISCHEMIA; HEART RATE VARIABILITY; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; MALE; PRIORITY JOURNAL; RR INTERVAL; SYMPATHETIC TONE; VAGUS TONE;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; ANGINA PECTORIS; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HEART RATE; HUMANS; ISOSORBIDE DINITRATE; MALE; METOPROLOL; MIDDLE AGED; VASODILATOR AGENTS;

EID: 0031916149     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000006762     Document Type: Article

References (40)

1. Kannel WB, Feinleib M: Natural history of angina pectoris in the Framingham Study. Am J Cardiol 1972;29:154-163.
2. Frank C, Weinblatt E, Shapiro S, Seiden GE, Sager RV: The HIP study of incidence and prognosis of coronary heart disease: Criteria for diagnosis. J Chron Dis 1963;16:1293-1312.
3. Rose G, Reid D, Hamilton PDS, Keen H, McCartney P, Jarrett R: Myocardial ischemia, risk factors and death from coronary heart disease. Lancet 1977;i:105-109.
4. Kleiger RE, Miller JP, Bigger JT, Moss AJ and the Multicenter Post-Infarction Research Group: Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987;59: 256-262.
5. Malik M, Farrell T, Camm J: Circadian rhythm of heart rate variability after acute myocardial infarction and its influence on the prognostic value of heart rate variability. Am J Cardiol 1990;66:1049-1054.
6. Rick MW, Saini JS, Kleiger RE, Carney RM, te Velde A, Freedland KE: Correlation of heart rate variability with clinical and angiographic variables and late mortality after coronary angiography. Am J Cardiol 1988;62:714-717.
7. Skinner JE, Lie JT, Entman ML: Modification of ventricular fibrillation latency following coronary artery occlusion in the conscious pig: The effects of psychological stress and beta-adrenergic blockade. Circulation 1975;51:656-667.
8. Gillis RA, Corr PB, Pace DG, Evans DE, Di-Micco J, Pearle DL: Role of the nervous system in experimentally induced arrhythmias. Cardiology 1976;61:37-49.
9. Verrier RL, Lown B: Autonomic nervous system and malignant cardiac arrhythmias; in Weiner H, Hofer MA, Stunkard AJ (eds): Brain Behaviour and Bodily Disease. New York, Raven Press, 1981, pp 273-291.
10. Kolman BS, Verrier RL, Lown B: The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: Role of sympathetic-para-sympathetic interactions. Circulation 1975;52: 578-585.
11. Cook JR, Bigger T Jr, Kleiger RE, Fleiss JL, Steinman RC, Rolnitzky LM: Effects of atenolol and diltiazem on heart period variability in normal persons. J Am Coll Cardiol 1991;17: 480-484.
12. Niemelä MJ, Airaksinen KEJ, Huikuri HV: Effect of betablockade on heart rate variability in patients with coronary artery disease. J Am Coll Cardiol 1994;23:1370-1377.
13. Molgaard A, Mickley H, Pless P, Bjerregaard P, Möller M: Effects of metoprolol on heart rate variability in survivors of acute myocardial infarction. Am J Cardiol 1993;71:1357-1359.
14. Norwegian Study Group: Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981;304:801-807.
15. Beta-Blocker Heart Attack Trial Research Group: A randomized trial of propranolol in patients with acute myocardial infarction. 1. Mortality results. JAMA 1982;247:1707-1713.
16. Hjalmarson Å, Herlitz J, Holmberg S, Rydén L, Swedberg K, Vedin A, Waagstein F. Waldenström A, Waldenström J, Wedel H, Wilhelmson I, Wilhelmson C: The Göteborg metoprolol trial: Effects on mortality and morbidity in acute myocardial infarction. Circulation 1983;67(suppl 1):I-26-I-32.
17. Rydén L, Ariniego R, Arnman K, Herlitz J, Hjalmarson Å, Holmberg S, Reyes C, Smedgård P, Swedberg K, Vedin A, Waagstein F, Waldenström A, Wilhelmson C, Wedel H, Yamamoto M: A double-blind trial of metoprolol in acute myocardial infarction: Effects on ventricular tachyarrhythmias. N Engl J Med 1983; 308:614-618.
18. Bishop V, Malliani A, Thorén P: Cardiac mechanoreceptors; in Shepherd JT, Abboud FM, Geiger SR (eds): Handbook of Physiology -The Cardiovascular System III. Bethesda, American Physiological Society, 1983, pp 497-555.
19. Guyton A: Local control of blood flow by the tissues, and humoral regulation; in Guyton AC, Hall JE (eds): Textbook of Medical Physiology, ed 8. Philadelphia, Saunders, 1991, pp 186-193.
20. Agabiti-Rosei E, Muiesan ML, Beschi M, Castellano M, Romanelli G, Cefis M, Cerri B, Pollavini G, Muiesan G: Antianginal efficacy of transdermal nitro-glycerine as related to adrenergic and renin-aldosterone systems (abstract). Circulation 1987;76(suppl IV):IV-128.
21. Parker JO, Parker JD: Neurohormonal activation during nitrate therapy: A possible mechanism for tolerance. Am J Cardiol 1992;70:93B-97B.
22. Imhof PR, Renwald D, Muller P, Howald H, Burkart F: Circulatory counter-regulations induced by continuous administration of nitro-glycerine. Methods Find Exp Clin Pharmacol 1989;11:409-414.
23. Dupuis J, Lalonde G, Lemieux R, Rouleau JL: Tolerance to intravenous nitroglycerin in patients with congestive heart failure: Role of increased intravascular volume, neurohormonal activation and lack of prevention with N-acetyl-cystein. J Am Coll Cardiol 1990;16:923-935.
24. Packer M: What causes tolerance to nitroglycerin? The 100-year-old mystery continues. J Am Coll Cardiol 1990;16:932-935.
25. Pantridge JF, Geddes JS: A mobile intensive care unit in the management of myocardial infarction. Lancet 1967;ii:271-273.
26. Cobb LA, Werner JA, Trobaugh GB: Sudden cardiac death. I. A decade's experience with out-of-hospital resuscitation. Mod Concepts Cardiovasc Dis 1980;49:31-36.
27. Wennerblom B, Ekström L, Holmberg S: Resuscitation of patients in cardiac arrest outside hospital: Comparing two different organizations of mobile coronary care in one community. Eur Heart J 1984;5:21-26.
28. Akselrod S, Gordon D, Ubel FA, Shannon DC, Barger AC, Cohen RJ: Power spectrum analysis of heart rate fluctuation: A quantitative probe of beat-to-beat cardiovascular control. Science 1981;213:220-222.
29. Pomeranz B, Macanlay RJB, Candill MA, Kutz I, Adam D, Gordon D, Kilborn KM, Barger AC, Shannon DC, Cohen RJ, Benson H: Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol 1985;248:H151-H153.
30. Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P, Sandrone G, Malfatto G, Dell'Orto S, Piccaluga E, Turiel M, Baselli G, Cerutti S, Malliani A: Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res 1986;59: 178-193.
31. Kjekshus JK: Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol 1986;57:43F-49F.
32. Wikstrand J, Kendall M: The role of betareceptor blockade in preventing sudden death. Eur Heart J 1992;13:111-120.
33. Åblad B, Bjurö T, Björkman JA, Edström T, Olsson G: Role of central nervous betareceptors in the prevention of ventricular fibrillation through augmentation of cardiac vagal tone (abstract). J Am Coll Cardiol 1991;17:165A.
34. Tuininga YS, van Veldhuisen DJ, Brouwer J, Haaksma J, Crijns JGM, Man in't Veld AJ, Lie KI: Heart rate variability in left ventricular dysfunction and heart failure: Effects and implication of drug treatment. Br Heart J 1994; 72:509-513.
35. Bigger JT, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN: Frequency domain measures of heart period variability and mortality after acute myocardial infarction. Circulation 1992;85:164-171.
36. Packer M, Lee WH, Kessler P, Gottlieb S, Medina N, Yushak M: Prevention and reversal of nitrate tolerance in patients with congestive heart failure. N Engl J Med 1987;317:799-804.
37. Esler M, Jennings G, Lambert G, Meredith I, Home M, Eisenhofer G: Overflow of catecholamine neurotransmitters to the circulation: Source, fate, and functions. Physiol Rev 1990; 70:963-985.
38. Schwarz P, Diem R, Dun NJ, Förstermann V: Endogenous and exogenous nitric oxide inhibits norepinephrine release from rat heart sympathetic nerves. Circ Res 1995;77:841-848.
39. Greenberg SS, Diecke FPJ, Cantor E, Peevy K, Tanaka TP: Inhibition of sympathetic neurotransmitter release by modulator of cyclic GMP in canine vascular smooth muscle. Eur J Pharmacol 1990;187:409-423.
40. Kleiger RE, Bigger JT, Bosner MS, Chung MK, Cook JR, Rolnitzky LM, Steinman R, Fleiss JL: Stability over time of variables measuring heart rate variability in normal subjects. Am J Cardiol 1991;68:626-630.